Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer

Clinical trial NCT06951399 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06951399
Sponsor: Rabin Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IV Without EGFR/ALK Mutation NSCLC Adenocarcinoma

Start date: 2025-09-01
Primary completion: 2027-08-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.